These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 6414696

  • 1. Mesna versus forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplant patients (preliminary data).
    Hows J, Mehta A, Gordon-Smith EC.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():53-6. PubMed ID: 6414696
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study.
    Hows JM, Mehta A, Ward L, Woods K, Perez R, Gordon MY, Gordon-Smith EC.
    Br J Cancer; 1984 Dec; 50(6):753-6. PubMed ID: 6437430
    [Abstract] [Full Text] [Related]

  • 3. Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation.
    Link H, Neef V, Niethammer D, Wilms K.
    Blut; 1981 Nov; 43(5):329-30. PubMed ID: 6799018
    [No Abstract] [Full Text] [Related]

  • 4. Experience with mesna in patients receiving allogeneic bone marrow transplants for poor prognostic leukaemia.
    Blacklock H, Ball L, Knight C, Schey S, Prentice G.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():45-52. PubMed ID: 6414695
    [No Abstract] [Full Text] [Related]

  • 5. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.
    Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL.
    J Clin Oncol; 1991 Nov; 9(11):2016-20. PubMed ID: 1941060
    [Abstract] [Full Text] [Related]

  • 6. [Usefulness of 2-mercaptoethanol sodium sulfonate (Mesnum) in the prevention of hemorrhagic cystitis in patients undergoing bone marrow transplantation].
    Grañena A, Gardella S, Marín P, Carreras E, Montserrat E, Rozman C.
    Sangre (Barc); 1986 Nov; 31(3):307-10. PubMed ID: 3092373
    [No Abstract] [Full Text] [Related]

  • 7. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis.
    Ehrlich RM, Freedman A, Goldsobel AB, Stiehm ER.
    J Urol; 1984 May; 131(5):960-2. PubMed ID: 6423841
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy.
    Haselberger MB, Schwinghammer TL.
    Ann Pharmacother; 1995 Sep; 29(9):918-21. PubMed ID: 8547741
    [Abstract] [Full Text] [Related]

  • 9. A new regimen of MESNA (2-mercaptoethanesulfonate) effectively prevents cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplant recipients.
    Khojasteh NH, Zakerinia M, Ramzi M, Haghshenas M.
    Transplant Proc; 2000 May; 32(3):596. PubMed ID: 10812128
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.
    Luce JK, Simons JA.
    Med Pediatr Oncol; 1988 May; 16(6):372-4. PubMed ID: 3143903
    [Abstract] [Full Text] [Related]

  • 11. Mesna and furosemide for prevention of cyclophosphamide-induced sterile haemorrhagic cystitis in dogs--a retrospective study.
    Laberke S, Zenker I, Hirschberger J.
    Vet Rec; 2014 Mar 08; 174(10):250. PubMed ID: 24463993
    [Abstract] [Full Text] [Related]

  • 12. National survey of use of mesna for the prevention of cyclophosphamide-induced hemorrhagic cystitis in recipients of bone marrow transplants.
    Nicolau DP, Hogan KR.
    Mayo Clin Proc; 1992 Jun 08; 67(6):611-2. PubMed ID: 1434892
    [No Abstract] [Full Text] [Related]

  • 13. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
    Andriole GL, Sandlund JT, Miser JS, Arasi V, Linehan M, Magrath IT.
    J Clin Oncol; 1987 May 08; 5(5):799-803. PubMed ID: 3106585
    [Abstract] [Full Text] [Related]

  • 14. Mesna and oxazaphosphorine cancer chemotherapy.
    Shaw IC.
    Cancer Treat Rev; 1987 Dec 08; 14(3-4):359-64. PubMed ID: 3125971
    [No Abstract] [Full Text] [Related]

  • 15. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation.
    Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P, Arthur RR, Jones RJ.
    J Clin Oncol; 1995 May 08; 13(5):1103-9. PubMed ID: 7738616
    [Abstract] [Full Text] [Related]

  • 16. Mesnum and cyclophosphamide cystitis.
    Lancet; 1980 Nov 29; 2(8205):1195. PubMed ID: 6107795
    [No Abstract] [Full Text] [Related]

  • 17. Hemorrhagic cystitis complicating bone marrow transplantation.
    Letendre L, Hoagland HC, Gertz MA.
    Mayo Clin Proc; 1992 Feb 29; 67(2):128-30. PubMed ID: 1545575
    [Abstract] [Full Text] [Related]

  • 18. Hemorrhagic cystitis, chemotherapy, and bladder toxicity.
    Ratliff TR, Williams RD.
    J Urol; 1998 Mar 29; 159(3):1044. PubMed ID: 9474228
    [No Abstract] [Full Text] [Related]

  • 19. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.
    Korkmaz A, Oter S, Deveci S, Goksoy C, Bilgic H.
    J Urol; 2001 Sep 29; 166(3):1119-23. PubMed ID: 11490309
    [Abstract] [Full Text] [Related]

  • 20. [The prevention of hemorrhagic cystitis during the performance of bone marrow and peripheral blood stem cell transplantation in the hematologic cancer clinic].
    Uss AL, Milanovich NF, Snegir' VM, Zmachinskiĭ VA, Skriagin AE.
    Ter Arkh; 1996 Sep 29; 68(10):49-52. PubMed ID: 9026944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.